[go: up one dir, main page]

MX2019003818A - Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo. - Google Patents

Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo.

Info

Publication number
MX2019003818A
MX2019003818A MX2019003818A MX2019003818A MX2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A
Authority
MX
Mexico
Prior art keywords
phenyl
derivative
synthesis
dropiran
hexahi
Prior art date
Application number
MX2019003818A
Other languages
English (en)
Other versions
MX382067B (es
Inventor
Wook Chung Jin
Ku Yoo Sang
Suk KANG Ku
Young Kim Jin
Geun Jo In
Ho IM Jeong
Young Kim Ji
Original Assignee
Glaceum Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum Inc filed Critical Glaceum Inc
Publication of MX2019003818A publication Critical patent/MX2019003818A/es
Publication of MX382067B publication Critical patent/MX382067B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a un método para la síntesis de un derivado de 3-fenil-2,3,4,8,9,10-hexahidropiran[2,3-f] cromeno y un isómero óptico del mismo, y un Compuesto intermedio que se puede utilizar para el método de síntesis, y cuando se utilizan el método y el Compuesto intermedio, el derivado de 3-fenil-2,3,4,8,9,10-hexahidropiran[2,3-f] cromeno y el isómero óptico del mismo se pueden sintetizar de manera eficaz.
MX2019003818A 2016-10-04 2017-09-27 Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropiran [2,3-f] cromeno e isómero óptico del mismo. MX382067B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160127805 2016-10-04
PCT/KR2017/010679 WO2018066872A1 (ko) 2016-10-04 2017-09-27 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법

Publications (2)

Publication Number Publication Date
MX2019003818A true MX2019003818A (es) 2019-08-12
MX382067B MX382067B (es) 2025-03-12

Family

ID=61831886

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003818A MX382067B (es) 2016-10-04 2017-09-27 Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropiran [2,3-f] cromeno e isómero óptico del mismo.

Country Status (18)

Country Link
US (2) US10669282B2 (es)
EP (1) EP3524609B1 (es)
JP (1) JP6810275B2 (es)
KR (2) KR20180037584A (es)
CN (1) CN109863152B (es)
AR (1) AR109735A1 (es)
AU (1) AU2017338514B2 (es)
CA (1) CA3039326C (es)
DK (1) DK3524609T3 (es)
ES (1) ES2881000T3 (es)
HU (1) HUE055701T2 (es)
IL (1) IL265706B (es)
MX (1) MX382067B (es)
PL (1) PL3524609T3 (es)
PT (1) PT3524609T (es)
TW (1) TWI641610B (es)
WO (1) WO2018066872A1 (es)
ZA (1) ZA201902760B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4023651B1 (en) * 2016-06-29 2023-09-13 Glaceum, Inc. Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
ES2881000T3 (es) * 2016-10-04 2021-11-26 Glaceum Inc Método para la preparación de un derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros ópticos del mismo e intermedios del proceso
TWI804600B (zh) * 2018-04-03 2023-06-11 南韓商格雷森伍股份有限公司 3-苯基-2,8-二氫吡喃[2,3-ƒ]苯并哌喃衍生物的合成方法
WO2020071818A1 (ko) * 2018-10-02 2020-04-09 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR102819124B1 (ko) * 2018-10-02 2025-06-12 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR20200105198A (ko) * 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
KR102692932B1 (ko) * 2019-07-30 2024-08-07 주식회사 글라세움 2-((6-(히드록시메틸)크로멘-5-일)옥시)-1-페닐에타논 유도체의 합성 방법
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물
CN116284031A (zh) * 2023-02-14 2023-06-23 陕西元亨医药科技有限责任公司 一种r-光甘草定的制备方法
CN119192191B (zh) * 2024-11-25 2025-03-04 山东第一医科大学(山东省医学科学院) 甲氧基化光甘草定类似物及其制备方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100565423B1 (ko) * 2003-10-20 2006-03-30 빅 바이오 주식회사 이소플라반 유도체 또는 이소플라벤 유도체의 제조방법
JP2006008604A (ja) * 2004-06-25 2006-01-12 Kuraray Co Ltd イソフラバン誘導体の製造方法
WO2007058480A1 (en) * 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
US8563599B2 (en) * 2008-03-03 2013-10-22 The United States Of America, Represented By The Secretary Of Agriculture Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof
CN101555259B (zh) * 2009-05-15 2012-06-27 中国科学院上海有机化学研究所 螺环骨架膦噁唑啉配体、合成方法及其在不对称氢化反应中的应用
CN103030647B (zh) 2013-01-16 2014-10-29 山东省分析测试中心 一种光甘草定的合成方法
KR102344479B1 (ko) 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
EP4023651B1 (en) * 2016-06-29 2023-09-13 Glaceum, Inc. Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
ES2881000T3 (es) * 2016-10-04 2021-11-26 Glaceum Inc Método para la preparación de un derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros ópticos del mismo e intermedios del proceso

Also Published As

Publication number Publication date
IL265706A (en) 2019-05-30
BR112019006736A8 (pt) 2022-08-23
IL265706B (en) 2021-06-30
JP2019529577A (ja) 2019-10-17
HUE055701T2 (hu) 2021-12-28
CN109863152A (zh) 2019-06-07
TWI641610B (zh) 2018-11-21
KR20180037584A (ko) 2018-04-12
PT3524609T (pt) 2021-07-15
US20200199142A1 (en) 2020-06-25
EP3524609B1 (en) 2021-05-26
US20200048272A1 (en) 2020-02-13
US10947250B2 (en) 2021-03-16
AU2017338514B2 (en) 2020-05-14
CA3039326A1 (en) 2018-04-12
TW201813970A (zh) 2018-04-16
ZA201902760B (en) 2021-09-29
KR20180091803A (ko) 2018-08-16
EP3524609A1 (en) 2019-08-14
EP3524609A4 (en) 2020-04-08
WO2018066872A1 (ko) 2018-04-12
MX382067B (es) 2025-03-12
BR112019006736A2 (es) 2019-07-23
DK3524609T3 (da) 2021-07-26
AR109735A1 (es) 2019-01-16
KR101893393B1 (ko) 2018-08-30
ES2881000T3 (es) 2021-11-26
CN109863152B (zh) 2021-12-03
US10669282B2 (en) 2020-06-02
NZ753171A (en) 2021-05-28
PL3524609T3 (pl) 2021-12-27
CA3039326C (en) 2022-09-20
JP6810275B2 (ja) 2021-01-06
AU2017338514A1 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
MX2019003818A (es) Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo.
AR132627A2 (es) Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos
CL2017002606A1 (es) Inhibidor de bromodominio
NI201600165A (es) Inhibidores de desmetilasa 1 específica a lisina
CL2018001899A1 (es) Salicilamidas de espiroheptanos y compuestos relacionados como inhibidores de cinasa rho (rock)
MX2018003280A (es) Proceso de compuesto antifungico.
MX375707B (es) Compuesto derivativo triciclico, metodo para prepararlo y composicion farmaceutica que comprende el mismo.
CR20150517A (es) Inhibidores de la phd de 6-(5-hidroxi-1h-pirazol-1-il) nicotinamida
MX2019011496A (es) Composiciones de niraparib.
UY36122A (es) ?derivados de pirrolidina-2,5-diona, composiciones farmacéuticas y métodos para usar como inhibidores ido1?
MX2019010642A (es) Inhibidores de cinasa activada por mitogeno 2 (mk2), sintesis de los mismos, e intermediarios de los mismos.
MX2017013629A (es) Metodos para mejora hidraulica de cultivos.
EP3504185A4 (en) NEW SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE (IDO)
MX387796B (es) Compuestos de aminocarbonilcarbamato.
BR112019020338A8 (pt) Composição para produção de tagatose, e, método de produção de tagatose
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
EA201892515A1 (ru) Стероидные 6,7-бета-эпоксиды в качестве интермедиатов
MX2019004434A (es) Anticuerpos anti-edb y conjugados anticuerpo-fármaco.
CR20160448A (es) Nuevos derivados de piridina
ECSP16074207A (es) Pirazinas moduladoras de gpr6
CL2020000376A1 (es) Compuesto pentacíclico.
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
MX2019002673A (es) Composiciones y metodos para tratar demencia.
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
ECSP17045054A (es) Derivados de fumagilol